NCT02390102View on ClinicalTrials.gov

Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement

PHASE3CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2016

Conditions
AnemiaAortic Stenosis
Interventions
DRUG

Erythropoietin

Combinaison drug of darboepoetin 0.75µg/Kg + 200mg intravenous iron sucrose

DRUG

Placebo

Saline solution 0.9%

Trial Locations (1)

G1V 4G5

Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Québec

All Listed Sponsors
lead

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

OTHER

NCT02390102 - Erythropoietin + Iron Therapy for Anemic Patients Undergoing Aortic Valve Replacement | Biotech Hunter | Biotech Hunter